Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 8/2012

01.08.2012 | Editorial Commentary

82Rb PET/CT: entering a new area of myocardial perfusion imaging?

verfasst von: Ines Valenta, Thomas Hellmut Schindler

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Excerpt

In this issue of the European Journal of Nuclear Medicine and Molecular Imaging, Flotats et al. [1] report a striking improvement in image quality of myocardial perfusion studies with the use of 82Rb PET/CT as compared to conventional 99mTc-labelled SPECT/CT. When using PET/CT in concert with the positron-emitting myocardial perfusion tracer 82Rb, the improvement in image quality also manifested in a higher interpretative confidence and interreader agreement of 82Rb perfusion images than observed for 99mTc-labelled SPECT/CT. In particular, the current study is unique in that 82Rb PET/CT and 99mTc-labelled SPECT/CT were performed in the same patient with known or suspected coronary artery disease (CAD). Previous investigations commonly compared the sensitivity and specificity of cardiac PET versus SPECT perfusion imaging in the detection of flow-limiting epicardial lesions [2]. For example, Go et al. [3] showed sensitivity, specificity and accuracy of 95, 82 and 92 % for 82Rb PET and 79, 76 and 78 % for 201Tl SPECT for haemodynamically obstructive CAD lesions. Further, Stewart et al. [4] reported that overall sensitivity, specificity and accuracy of 82Rb PET for detection of coronary artery lesions ≥50 % diameter stenosis were 84, 88 and 85 %, respectively. In comparison to this, the performance of 201Tl SPECT revealed a sensitivity of 84 % but a low specificity of 53 % and a diagnostic accuracy of 79 %. The commonly higher sensitivity in the identification of flow-limiting epicardial lesions with 82Rb PET as compared with SPECT imaging, either with 201Tl or 99mTc-labelled perfusion tracers, can be related to the higher spatial and contrast resolution of 82Rb PET, while the photon attenuation–free images of PET imaging may account for the relative increase in specificity [2]. …
Literatur
1.
Zurück zum Zitat Flotats A, Bravo PE, Fukushima K, Chaudry M, Merrill J, Bengel FM. 82Rb-PET myocardial perfusion imaging is superior to 99mTc-labelled agent SPECT in patients with known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2012. doi:10.1007/s00259-012-2140-x. Flotats A, Bravo PE, Fukushima K, Chaudry M, Merrill J, Bengel FM. 82Rb-PET myocardial perfusion imaging is superior to 99mTc-labelled agent SPECT in patients with known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2012. doi:10.​1007/​s00259-012-2140-x.
2.
Zurück zum Zitat Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging 2010;3(6):623–40.PubMedCrossRef Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging 2010;3(6):623–40.PubMedCrossRef
3.
Zurück zum Zitat Go RT, Marwick TH, MacIntyre WJ, Saha GB, Neumann DR, Underwood DA, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31(12):1899–905.PubMed Go RT, Marwick TH, MacIntyre WJ, Saha GB, Neumann DR, Underwood DA, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31(12):1899–905.PubMed
4.
Zurück zum Zitat Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67(16):1303–10.PubMedCrossRef Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67(16):1303–10.PubMedCrossRef
5.
Zurück zum Zitat Garcia EV, Faber TL. Advances in nuclear cardiology instrumentation: clinical potential of SPECT and PET. Curr Cardiovasc Imaging Rep 2009;2:230–7.CrossRef Garcia EV, Faber TL. Advances in nuclear cardiology instrumentation: clinical potential of SPECT and PET. Curr Cardiovasc Imaging Rep 2009;2:230–7.CrossRef
6.
Zurück zum Zitat Bengel FM, Higuchi T, Javadi MS, Lautamäki R. Cardiac positron emission tomography. J Am Coll Cardiol 2009;54(1):1–15.PubMedCrossRef Bengel FM, Higuchi T, Javadi MS, Lautamäki R. Cardiac positron emission tomography. J Am Coll Cardiol 2009;54(1):1–15.PubMedCrossRef
7.
Zurück zum Zitat Ghosh N, Rimoldi OE, Beanlands RS, Camici PG. Assessment of myocardial ischaemia and viability: role of positron emission tomography. Eur Heart J 2010;31(24):2984–95.PubMedCrossRef Ghosh N, Rimoldi OE, Beanlands RS, Camici PG. Assessment of myocardial ischaemia and viability: role of positron emission tomography. Eur Heart J 2010;31(24):2984–95.PubMedCrossRef
8.
Zurück zum Zitat Garcia EV. Physical attributes, limitations, and future potential for PET and SPECT. J Nucl Cardiol 2012;19(Suppl 1):S19–29.PubMedCrossRef Garcia EV. Physical attributes, limitations, and future potential for PET and SPECT. J Nucl Cardiol 2012;19(Suppl 1):S19–29.PubMedCrossRef
9.
Zurück zum Zitat Fiechter M, Ghadri JR, Wolfrum M, Kuest SM, Pazhenkottil AP, Nkoulou RN, et al. Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device. Eur J Nucl Med Mol Imaging 2012;39(3):430–6.PubMedCrossRef Fiechter M, Ghadri JR, Wolfrum M, Kuest SM, Pazhenkottil AP, Nkoulou RN, et al. Downstream resource utilization following hybrid cardiac imaging with an integrated cadmium-zinc-telluride/64-slice CT device. Eur J Nucl Med Mol Imaging 2012;39(3):430–6.PubMedCrossRef
10.
Zurück zum Zitat Kaufmann PA. 82-Rubidium—the dawn of cardiac PET in Europe? Eur J Nucl Med Mol Imaging 2007;34(12):1963–4.PubMedCrossRef Kaufmann PA. 82-Rubidium—the dawn of cardiac PET in Europe? Eur J Nucl Med Mol Imaging 2007;34(12):1963–4.PubMedCrossRef
Metadaten
Titel
82Rb PET/CT: entering a new area of myocardial perfusion imaging?
verfasst von
Ines Valenta
Thomas Hellmut Schindler
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 8/2012
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-012-2154-4

Weitere Artikel der Ausgabe 8/2012

European Journal of Nuclear Medicine and Molecular Imaging 8/2012 Zur Ausgabe